Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD5 | P21918 | 6/20 | 0.39 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.37 |
| ▸ | KDM1A | O60341 | 2/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | EED | O75530 | 3/20 | 0.32 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.32 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.30 |
| ▸ | TFPI2 | P48307 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24110284 | 1.00 | DRD5 (0.39) | DRD5SCN9AKDM1AHTR2AHTR2C | |
| SCHEMBL24110279 | 0.95 | DRD5 (0.39) | DRD5SCN9AKDM1AHTR2AHTR2C | |
| SCHEMBL25825509 | 0.95 | DRD5 (0.39) | DRD5SCN9AKDM1AHTR2AHTR2C | |
| SCHEMBL25825528 | 0.89 | TFPI2 (0.37) | SCN9ASLC6A2SLC6A4TFPI2 | |
| SCHEMBL24110199 | 0.89 | TFPI2 (0.37) | SCN9ASLC6A2SLC6A4TFPI2 | |
| SCHEMBL24110636 | 0.89 | SCN9A (0.40) | DRD5SCN9AKDM1AHTR2AHTR2C | |
| SCHEMBL25820515 | 0.86 | HTR2A (0.43) | SCN9AHTR2AHTR2C | |
| SCHEMBL24110263 | 0.86 | HTR2A (0.43) | SCN9AHTR2AHTR2C | |
| SCHEMBL24110195 | 0.86 | SLC6A2 (0.32) | SCN9AEEDSLC6A2SLC6A4TFPI2 | |
| SCHEMBL25825529 | 0.86 | SLC6A2 (0.32) | SCN9AEEDSLC6A2SLC6A4TFPI2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230219969-A1 | ISOTRYPTAMINE PSYCHOPLASTOGENS AND USES THEREOF | DELIX THERAPEUTICS, INC. | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230219969-A1 | ISOTRYPTAMINE PSYCHOPLASTOGENS AND USES THEREOF | GAP43, SLC18A2, PNMT | DRD5 252/4885SCN9A 3315/4885KDM1A 2003/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.